HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clairol Hair Care Brands Show Double-Digit Sales Growth In 1999

This article was originally published in The Rose Sheet

Executive Summary

Clairol Herbal Essences sales grew 14% to $637 mil. for the year and increased 6% to $151 mil. for the fourth quarter, the company reported Jan. 24. Clairol continues to be the number one hair products company in the U.S., Bristol-Myers Squibb said.

You may also be interested in...



Matrix

Bristol-Myers Squibb seeks to divest Matrix Essentials hair care subsidiary in order to concentrate on Clairol retail and professional beauty care global businesses. The $340 mil. Matrix subsidiary, which includes the Biolage, Amplify, Vavoom, Icon, Logics and Via Dezign brands, is available in 65,000 U.S. salons in addition to distribution in Europe and the Pacific Rim. Bristol's beauty sales totaled $624 mil. through Sept. 30, making Matrix roughly a third of the company's overall beauty sales. BMS hopes to find a company to purchase the business in full, including the 100 Matrix employees

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007597

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel